Workflow
NVN
icon
Search documents
Switch的救世主是老黄!?
量子位· 2025-07-15 06:28
henry 发自 凹非寺 量子位 | 公众号 QbitAI Switch2发售后,内置图形API——NVN2首次公开亮相 。 相较前代Switch发热、卡顿、续航短、画质缩水等问题,搭载英伟达NVN2的Switch2显然从容得多,面对各类3A大作也毫不吃力。 《赛博朋克2077》的联合开发者 Eoin O'Grady 表示,只要是Xbox上能跑满60帧的游戏,移植到Switch2几乎都不在话下。 而在NVN2背后的,是任天堂与英伟达长达十年的深度合作—— 一段曾被许多人忽视的技术联姻。 当任天堂遇上英伟达 今年6月初,Switch2发售短短4天,销量突破350万台,刷新任天堂历史最快销售纪录。 但把时间拨回十多年前,任天堂和英伟达远不如现在这么风光。 彼时的任天堂 受Switch上一代掌机WiiU销量惨淡和快速崛起的手游冲击,在2013年利润暴跌三成。WiiU更是成为任天堂有史以来销量最差 的游戏机,时任任天堂社长岩田聪带领一众高管降薪。 为挽颓势,岩田聪将目光投向开发新的移动游戏硬件,Switch的雏形由此而生——一款结合主机和掌机的新产品。 但"既要性能、又要便携"的需求,使任天堂无法走传统家用主机的路线 ...
gammaCore Non-Invasive Vagus Nerve Stimulation (nVNS) Shown to be Effective in Treating Concussive Symptoms Associated with Mild Traumatic Brain Injuries
Newsfilter· 2025-04-17 12:00
Core Insights - electroCore, Inc. announced new data at the 2025 International Brain Injury Association World Congress, highlighting the effectiveness of gammaCore® non-invasive vagus nerve stimulation (nVNS) in treating concussive symptoms associated with mild traumatic brain injury (mTBI) [1][3] Study Findings - A study involving 102 patients with mild TBI showed that adjunctive use of gammaCore (nVNS) significantly improved 22 out of 27 measured concussive symptoms, with notable improvements in post-traumatic headache, nausea, dizziness, and depression [3] - The study indicated no significant difference in symptom improvement between patients with recent traumatic brain injuries (three months or less) and those with older injuries (three years or more), suggesting the potential benefits of neuromodulation regardless of the time since injury [3] Expert Commentary - Dr. Michael Ament emphasized the urgent need for nonpharmaceutical treatment options for mild TBI, reinforcing the role of vagus nerve stimulation in alleviating long-term effects [2][4] - Dr. Peter Staats, Chief Medical Officer of electroCore, praised Dr. Ament's research for demonstrating the clinical efficacy of gammaCore in improving concussive symptoms in a large patient cohort [4] Company Overview - electroCore, Inc. is a commercial-stage bioelectronic medicine and wellness company focused on improving health through its nVNS technology platform, aiming to commercialize medical devices for managing and treating specific medical conditions [5]